NCT06628570 Screening Strategies Among High-risk Populations for Anal Cancer
| NCT ID | NCT06628570 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lisa Flowers |
| Condition | Neoplasms |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-12-16 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2024-12-16 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the proposed research is to 1) examine the performance of emerging screening methods for anal high-grade squamous intraepithelial lesion (aHSIL), a precancerous condition of anal cancer, among populations at high risk for anal cancer and 2) characterize DNA methylation, immunologic response, and environmental factors associated with aHSIL.
Eligibility Criteria
Inclusion Criteria: * 30-80 years of age * Individuals with chronic impaired immune status * History of lower genital tract neoplasia (LGTN), Zubrod Performance Status of 0-2 Exclusion Criteria: * Patients treated for aHSIL less than 6 months before screening * History of anal cancer and pregnant women.
Contact & Investigator
Lisa Flowers, MD, MPH
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT06628570 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 80 Years, studying Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06628570 currently recruiting?
Yes, NCT06628570 is actively recruiting participants. Contact the research team at lflowe2@emory.edu for enrollment information.
Where is the NCT06628570 trial being conducted?
This trial is being conducted at Miami, United States, Miami, United States, Atlanta, United States, Atlanta, United States.
Who is sponsoring the NCT06628570 clinical trial?
NCT06628570 is sponsored by Lisa Flowers. The principal investigator is Lisa Flowers, MD, MPH at Emory University. The trial plans to enroll 500 participants.